Nuveen LLC Invests $1.77 Million in Enhabit, Inc. $EHAB

Key Points

• Nuveen LLC acquired 201,681 shares of Enhabit, Inc. (NYSE:EHAB), worth approximately $1.77 million, during the first quarter, representing about 0.40% of the company's stock.
• Enhabit recently reported earnings of $0.13 per share, surpassing estimates, and its revenue reached $266.1 million for the quarter.
• UBS Group lowered its target price for Enhabit from $10.00 to $8.50, giving the stock a "neutral" rating, while the average target price among analysts is $8.67.

Nuveen LLC bought a new stake in Enhabit, Inc. (NYSE:EHAB - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 201,681 shares of the company's stock, valued at approximately $1,773,000. Nuveen LLC owned about 0.40% of Enhabit at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Enhabit by 4.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 28,565 shares of the company's stock valued at $223,000 after purchasing an additional 1,216 shares during the last quarter. Mackenzie Financial Corp boosted its stake in shares of Enhabit by 12.1% in the 1st quarter. Mackenzie Financial Corp now owns 14,468 shares of the company's stock valued at $127,000 after purchasing an additional 1,564 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Enhabit by 295.2% in the 1st quarter. GAMMA Investing LLC now owns 3,533 shares of the company's stock valued at $31,000 after purchasing an additional 2,639 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of Enhabit by 10.3% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 43,851 shares of the company's stock valued at $343,000 after purchasing an additional 4,100 shares during the last quarter. Finally, Group One Trading LLC boosted its stake in shares of Enhabit by 248.3% in the 4th quarter. Group One Trading LLC now owns 7,746 shares of the company's stock valued at $60,000 after purchasing an additional 5,522 shares during the last quarter.

Enhabit Stock Down 0.3%

EHAB traded down $0.03 during trading on Thursday, reaching $7.84. The company had a trading volume of 240,471 shares, compared to its average volume of 488,239. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.57 and a quick ratio of 1.57. Enhabit, Inc. has a 12 month low of $6.47 and a 12 month high of $10.90. The business's fifty day moving average price is $7.45 and its 200 day moving average price is $8.46. The company has a market cap of $397.16 million, a P/E ratio of -2.93 and a beta of 1.69.

Enhabit (NYSE:EHAB - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.13 earnings per share for the quarter, beating analysts' consensus estimates of $0.10 by $0.03. Enhabit had a negative net margin of 12.84% and a positive return on equity of 2.72%. The firm had revenue of $266.10 million for the quarter, compared to analyst estimates of $263.39 million. Equities analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current year.

Insiders Place Their Bets

In related news, CFO Ryan Solomon purchased 10,000 shares of the business's stock in a transaction on Friday, August 8th. The shares were purchased at an average price of $7.64 per share, with a total value of $76,400.00. Following the completion of the purchase, the chief financial officer owned 193,468 shares in the company, valued at $1,478,095.52. This represents a 5.45% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 3.40% of the company's stock.

Wall Street Analyst Weigh In

Separately, UBS Group reduced their target price on shares of Enhabit from $10.00 to $8.50 and set a "neutral" rating on the stock in a research note on Friday, August 8th. One analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Enhabit has a consensus rating of "Hold" and an average price target of $8.67.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.